Navigation Links
Suppression of Enzyme Delays a Type of Breast Cancer

Canadian researchers have disclosed that suppression of an enzyme called PTP1B stalls the advancement of a specific type of breast cancer//. This study was conducted on laboratory mice which were genetically modified to develop into a breast cancer condition of humans.

This research headed by Michel L.Tremblay along with Sophie Julien of McGill cancer Center, Quebec delayed the advancement of a particular kind of breast cancer linked to ERBB2 gene. In this case, the breast tumor appeared almost eight weeks later and lung metastases did not happen. In some mice cancer did not develop at all.

On the other hand, when the enzyme PTP1B was expressed it resulted in the development of cancer. Understanding of the relationship between this enzyme and breast cancer is likely to go a long way in treatment of this disease.

Clinical trials of a drug with inhibitory reaction to this protein are underway. There is already a research finding which claims that diabetes 2 and obesity can be treated by this enzyme suppression. In addition to this, PTP1B inhibitors have been developed by drug companies too.

Testing of this inhibitor on humans could begin by 2008. These inhibitors alone or along with another drug could be used in the treatment of breast cancer patients. Currently Herceptin or Trastuzumab is being used.

According to these scientists though there is lot of work to be done in this field, this finding is sure to have a positive impact on further research in this topic.


JYT
'"/>




Page: 1

Related medicine news :

1. Adrenal Suppression not predicted by inhaled corticosteroids
2. Transplant Cures Rats’ Type 2 Diabetes without Need for Immune Suppression Drug
3. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
4. Should Menstrual Suppression Be a Lifestyle Choice?
5. Enzyme may be target for obesity drugs
6. Researchers trick Alzheimers Enzyme
7. Enzyme stimulates growth of adult stem cells
8. Enzyme may aid hold back disease
9. Enzyme help destroy cancer cell
10. Enzyme Associated with Memory
11. Enzyme Associated With Memory
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Suppression Enzyme Delays Type Breast Cancer

(Date:9/2/2015)... FRANCE (PRWEB) , ... September 02, 2015 , ... ... , PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth ... This new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil ...
(Date:9/2/2015)... ... 2015 , ... Pentec Health, Inc., a national leader in outsourced pharmacy services, ... consecutive year. Less than 5 % of this year’s 5000 honorees share the “six-time” ... Pentec’s 3-year revenue growth rate of 65% sustained its most recent achievement. As an ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/1/2015)... Spring Lake, NJ (PRWEB) , ... September 01, ... ... physician, has a reputation for the telling the truth about medicine and health, ... has created a video blog, where he plans to regularly debunk certain misconceptions ...
(Date:9/1/2015)... ... 01, 2015 , ... September is National Prostate Cancer Awareness Month and Florida ... men each year in the United States. , Prostate cancer is to men what ... affecting 1 in 7 men. One new case occurs every 2.3 minutes and a ...
Breaking Medicine News(10 mins):Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... conducted survey has revealed that Irish hospitals are definitely ... ,The study carried out between February and ... Infection Society //looked into 75,000 cases has revealed that ... contracted during the stay at health centers across Ireland. ...
... fresh out of the college, are yet to land a permanent ... which sought responses from 500 newly qualified nurses and more than ... yet ended for a band 5 nursing job, which is the ... sentiment among nearly 86% of the nurses, who were not positive ...
... prefer not step in to fast-track a merger between Albury-Wodonga's ... with Tony Abbott and Goulburn Murray politicians yesterday. ,A ... governments has still not revealed a common plan towards working ... work as one. ,Mr Abbott states that the must ...
... According to researchers, stress among youth associated with parental ... ,The researchers at the John Moores University in Liverpool ... at times parents in recognizing the physical and emotional ... poor physical and mental health. ,According to ...
... Cancer drug Velcade has been banned in England because the ... Excellence (NICE) has refused// to fund treatment, according to last ... week that Velcade should not be offered on the NHS ... Presently a course of Velcade has been estimated to cost ...
... All batches of the paracetamol tablet Paratabs 500mg are being ... contamination which is most likely to be mould//. This applies ... could not have purchased the product without a prescription , ... their pharmacy and not to consume anymore Paratabs, while ...
Cached Medicine News:Health News:Stress brings about early onset of puberty 2
(Date:9/2/2015)... LONDON , Sept. 2, 2015 The ... 30 marketed branded drugs and hundreds of generics. While ... share of branded therapeutics is expected to increase to ... to the development and launch of novel pipeline products ... therapeutics is the largest in terms of revenues, driven ...
(Date:9/1/2015)... and BEDFORD, Mass. , ... Arroyo LLP is investigating whether certain officers ... Securities and Exchange Act of 1934.  ConforMIS is a ... platform to develop, manufacture, and sell joint replacement implants ... patient,s unique anatomy. View this press release ...
(Date:9/1/2015)... and Delaware , United ... (ASX: IVX; "Company" or "Invion"), is pleased to announce that ... securities to an institutional investor in the United ... proceeds of approximately A$1.001 million ("Placement") by the issue of ... of $0.014 per share. The Company has ...
Breaking Medicine Technology:Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 2Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 3Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3
... standard, corrected curve trial lenses are ground with ... Marco refractors and are invaluable in treating low ... other manufacturers contain a disproportionately large number of ... expensive to produce, and fewer lenses in the ...
The LM-990A is the most completely automatic lensemeter ever created. It even measured monocular and binocular PD automatically....
... has made the LM-770 the easiest ... Technicians can be trained to operate ... instruction. The instrument tells the user ... A flashing indicator alerts the user ...
... designed to perform precise and accurate ... one-third the space of traditional examinations. ... refractors, automatic or digital lensmeters and ... EPIC enables the operator to call ...
Medicine Products: